A closer look at what well be monitoring in the new year
Researchers observe a marked increase in metabolic expenditure and mitochondrial biogenesis within treated isolated cell cultures
Currently, Medicare plans typically dont cover Wegovy for weight loss, but they may cover it for cardiovascular risk reduction
Impairment Of fertility Studies in which male and female rats received twice daily subcutaneous doses lixisenatide of 2, 29, or 414 mcg/kg prior to pairing through gestation day 6 did not indicate any adverse effects on male or female fertility in rats up to the highest dose tested, 414 mcg/kg, or approximately 400times the clinical systemic exposure at 20 mcg/day based on mcg/m
These risks and others described in the Risk Factors section of each of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and any of our subsequent filings with the Commission may not be exhaustive